Symposium on advanced therapy
Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia
Showing 921 - 940 of 1379 results
Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia
An article in Nature Geosciences has highlighted the power of synchrotron techniques to reveal the inner workings of volcanic systems that could potentially help with predictions of eruptions.
The outcome could have significant implications for better monitoring, management and remedial action of groundwater globally.
ANSTO and the Embassy of Argentina in Australia proudly hosted an event commemorating the 15th anniversary of the opening of the Open Pool Australian Lightwater (OPAL) multi-purpose nuclear reactor on 18 October.
Atomic structure of new cathode material for sodium ion batteries helps explain long life
Investigators from UNSW and ANSTO have provided insights into the dynamic interactions of atoms in a promising material for sodium-ion batteries.
In 2017, ANSTO's CEO signed a Memorandum of Understanding with Sri Lanka to work together to investigate the epidemiology of Chronic Kidney Disease of unknown origin (CKDu).
Scandium 47, a therapeutic radioisotope and potential theranostic, has been produced for the first time at ANSTO. Theranostics are used to both diagnose and treat disease.
Role at ANSTO
Inaugural speaker returns to deliver lecture on progress of the world largest engineering project to create fusion energy
ANSTO may provide travel and accommodation support to successful grant applicants from AINSE member organisations. Travel funds granted are to be used solely to cover the majority of the cost to travel to Sydney.
Australia launched a new international development project in partnership with the International Atomic Energy Agency (IAEA) to advance ‘Rays of Hope’ in the Asia and Pacific region.
New screening method developed to confirm if deuteration improves metabolic stability.
Close to 3000 members of the public decided to have a look at a building that is shaped like a doughnut, is as big as a football field and creates light more powerful than the sun when the Australian Synchrotron held its bi-annual Open Day held on Sunday, 16 October.
Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.